TL;DR
In recurrent diseases, surgery remains a main piece of treatment in case of late relapse and medical treatment depends on drugs used in the first line; in early platinum resistant relapse, a new therapeutic option is available with mirvétuximab soravtansine.
AI-generated by Semantic Scholar
Authors
Frédéric Selle, Manuel Rodrigues, Benoît You, Laurence Gladieff, Anne-Claire Hardy-Bessard, Thibault de la Motte Rouge, Jean-David Fumet, Olivia Le Saux, Pierre-Emmanuel Colombo, Gabriel Ferron, Isabelle Treilleux, Etienne Rouleau, Claire Falandry, Florence Joly, Jean-Sébastien Frénel, Stanislas Quesada, Jean-Marc Classe
